453 related articles for article (PubMed ID: 12199724)
61. Gabapentin as adjunctive therapy for partial seizures.
Bruni J
Epilepsia; 1999; 40 Suppl 6():S27-8; discussion S73-4. PubMed ID: 10530680
[TBL] [Abstract][Full Text] [Related]
62. Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study.
Mayer T; Schütte W; Wolf P; Elger CE
Acta Neurol Scand; 1999 Jan; 99(1):1-7. PubMed ID: 9925232
[TBL] [Abstract][Full Text] [Related]
63. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
Evans BK; Kustra RP; Hammer AE
Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
[TBL] [Abstract][Full Text] [Related]
64. New antiepileptic drugs: a systematic review of their efficacy and tolerability.
Marson AG; Kadir ZA; Chadwick DW
BMJ; 1996 Nov; 313(7066):1169-74. PubMed ID: 8916746
[TBL] [Abstract][Full Text] [Related]
65. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L;
Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
[TBL] [Abstract][Full Text] [Related]
66. New antiepileptic drugs for children: felbamate, gabapentin, lamotrigine, and vigabatrin.
Devinsky O; Vazquez B; Luciano D
J Child Neurol; 1994 Oct; 9 Suppl 1():S33-45. PubMed ID: 7822751
[TBL] [Abstract][Full Text] [Related]
67. Gabapentin in refractory partial epilepsy--a trial in India.
Dixit SN; Jain S; Padma MV; Maheshwari MC
Acta Neurol Scand; 1996; 93(2-3):85-7. PubMed ID: 8741123
[TBL] [Abstract][Full Text] [Related]
68. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
[TBL] [Abstract][Full Text] [Related]
69. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.
Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R
Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069
[TBL] [Abstract][Full Text] [Related]
70. Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study.
Matsuo F; Gay P; Madsen J; Tolman KG; Rollins DE; Risner ME; Lai AA
Epilepsia; 1996 Sep; 37(9):857-62. PubMed ID: 8814098
[TBL] [Abstract][Full Text] [Related]
71. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89.
Bergey GK; Morris HH; Rosenfeld W; Blume WT; Penovich PE; Morrell MJ; Leiderman DB; Crockatt JG; LaMoreaux L; Garofalo E; Pierce M
Neurology; 1997 Sep; 49(3):739-45. PubMed ID: 9305334
[TBL] [Abstract][Full Text] [Related]
72. [Trials with gabapentin monotherapy in patients with complex partial or secondary generalized seizures].
Pierce MW; Shokry A
Praxis (Bern 1994); 1997 Sep; 86(37):1430-1. PubMed ID: 9381042
[TBL] [Abstract][Full Text] [Related]
73. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group.
Brodie MJ; Richens A; Yuen AW
Lancet; 1995 Feb; 345(8948):476-9. PubMed ID: 7710545
[TBL] [Abstract][Full Text] [Related]
74. An audit of the new antiepileptic drugs in clinical neurological practice.
McDonnell GV; Morrow JI
Seizure; 1996 Jun; 5(2):127-30. PubMed ID: 8795128
[TBL] [Abstract][Full Text] [Related]
75. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy.
Werhahn KJ; Trinka E; Dobesberger J; Unterberger I; Baum P; Deckert-Schmitz M; Kniess T; Schmitz B; Bernedo V; Ruckes C; Ehrlich A; Krämer G
Epilepsia; 2015 Mar; 56(3):450-9. PubMed ID: 25684224
[TBL] [Abstract][Full Text] [Related]
76. Guidelines for treating epilepsy in the age of felbamate, vigabatrin, lamotrigine, and gabapentin.
Laxer KD
West J Med; 1994 Sep; 161(3):309-14. PubMed ID: 7975572
[TBL] [Abstract][Full Text] [Related]
77. [Clinical application of newer anti-epileptic drugs].
Terada K; Inoue Y
Rinsho Shinkeigaku; 2012; 52(11):1088-90. PubMed ID: 23196525
[TBL] [Abstract][Full Text] [Related]
78. Rapid initiation of gabapentin: a randomized, controlled trial.
Fisher RS; Sachdeo RC; Pellock J; Penovich PE; Magnus L; Bernstein P
Neurology; 2001 Mar; 56(6):743-8. PubMed ID: 11274308
[TBL] [Abstract][Full Text] [Related]
79. New antiepileptic drugs: comparison of key clinical trials.
Cramer JA; Fisher R; Ben-Menachem E; French J; Mattson RH
Epilepsia; 1999 May; 40(5):590-600. PubMed ID: 10386528
[TBL] [Abstract][Full Text] [Related]
80. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
